The concentration of CRP may progressively rise due to chronic inflammation and cytokines activation in both T2DM and GDM patients that may be extended to diabetic angiopathy, vessel damage and nephropathy caused by concomitant endocrine disturbances. This evidence concerns the gene CRP and kidney disorder.